Stephen R. Fussell, Executive Vice President at ABBOTT LABORATORIES (ABT), bought 12,200 shares at $40.77 ($497K) on 2017-01-31, disclosed to the SEC on 2017-02-02.
Scheduled purchase ($497k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ABT | SELL | 2018-03-02 | $668K | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.2M | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.9M | — | Filing → |